SCHEMBL7965261

SCHEMBL7965261

COCc1nc2c(O)cccc2n1C

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 1/20 0.43
TP53 P04637 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
RAB9A P51151 10/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NPC1 O15118 8/20 0.40
KDM4E B2RXH2 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
ALOX12 P18054 1/20 0.40
HTT P42858 1/20 0.40
LMNA P02545 3/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
TSHR P16473 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14685304 0.83 TSHR (0.45) TLR8TP53SMN1; SMN2RAB9AL3MBTL1
SCHEMBL7975692 0.82 TLR8 (0.49) TLR8SMN1; SMN2RAB9ANPC1KDM4E
SCHEMBL15780481 0.82 TSHR (0.39) TP53SMN1; SMN2RAB9AL3MBTL1NPC1
SCHEMBL14685303 0.81 RAB9A (0.57) TLR8TP53SMN1; SMN2RAB9AL3MBTL1
SCHEMBL12362614 0.81 DPP4 (0.44) TP53SMN1; SMN2RAB9AL3MBTL1NPC1
SCHEMBL14685206 0.80 TP53 (0.43) TP53SMN1; SMN2RAB9AL3MBTL1NPC1
SCHEMBL14685305 0.79 TP53 (0.39) TP53SMN1; SMN2RAB9AL3MBTL1NPC1
SCHEMBL14685299 0.78 RAB9A (0.50) TP53SMN1; SMN2RAB9AL3MBTL1NPC1
SCHEMBL14685306 0.77 SMN1; SMN2 (0.38) TP53SMN1; SMN2RAB9AL3MBTL1NPC1
SCHEMBL15782104 0.77 RAB9A (0.49) TLR8TP53SMN1; SMN2RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194396-B1 ANTIALLERGENS; ANTIINFLAMMATION AGENTS; AUTOIMMUNE DISEASE; ANTISHOCK AGENTS; ANALGESICS; E.G., A 4 OR 7-PHENYLALKYLENE-OXYBENZIMIDAZOLE UNSUBSTITUTED OR SUBSTITUTED IN THE 1,2,3-POSITION WITH AN OXY, AMINO AND/OR THIO GROUP FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-02-27 US disclosed
US-6083961-A FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 US disclosed
EP-0774462-A1 HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-05-21 EP disclosed